Preview

Bashkortostan Medical Journal

Advanced search

CLINICAL AND MORPHOLOGICAL FEATURES OF UTERINE FIBROID IN PATIENTS OF REPRODUCTIVE AGE

Abstract

Aim: to establish the clinical and morphological features of uterine fibroids, depending on the level of expression α-SMA, CD34, Ki-67 receptors.Material and methods. We carried out a retrospective analysis of the case histories of patients diagnosed with uterine fibroidsafter surgical treatment in the gynecological department of the clinic of obstetrics and gynecology of the Medical Academy named after S.M. Kirov for the period of 2017-2020.In total, the study included data from the case histories of 110 patients who underwent laparoscopic myomectomy. The size ofthe removed tumor exceeded 8 cm. According to the results of immunohistochemical studies, the patients were divided into 2 groups: the expression of α-SMA, CD34, Ki-67 less than 1% - 1 group (n = 58), the expression of α-SMA, CD-34, Ki-67 from 1% -5% - group 2 (n = 52).Statistical analysis was carried out using Microsoft Office Excel programs and R - Studio software environment.Results. The increased expression level of α-SMA, CD34, Ki-67 (1-5%) is reliably associated with multiple uterine myoma (p = 0.0003), rapid growth of the myoma node (p = 0.004). Also, a significant correlation was found between the volume of intraoperative blood loss and the degree of expression of proliferation receptors (p = 0.0007).Conclusion. Increased expression of proliferation factors can be considered as a criterion for predicting recurrence of fibroids in patients of reproductive age, which determines the need for dynamic monitoring and preventive anti-relapse therapy.

About the Authors

K. M. Atayants
ФГБВОУ ВО «Военно-медицинская академия имени С.М. Кирова» МО РФ
Russian Federation


T. E. Kurmanbaev
ФГБВОУ ВО «Военно-медицинская академия имени С.М. Кирова» МО РФ
Russian Federation


Yu. L. Timoshkova
ФГБВОУ ВО «Военно-медицинская академия имени С.М. Кирова» МО РФ
Russian Federation


A. A. Shmidt
ФГБВОУ ВО «Военно-медицинская академия имени С.М. Кирова» МО РФ
Russian Federation


M. V. Kubasov
ФГБВОУ ВО «Военно-медицинская академия имени С.М. Кирова» МО РФ
Russian Federation


A. A. Kuzheniyazov
ФГБВОУ ВО «Военно-медицинская академия имени С.М. Кирова» МО РФ
Russian Federation


References

1. Epidemiology of uterine myomas: a review // R.Sparic [et al.].- International journal of fertility & sterility. - 2016. - Т.9, №4. - С. 424. DOI: 10.22074/ijfs.2015.4599

2. Миома матки. Клинические рекомендации. ООО «Российское общество акушеров-гинекологов» (РОАГ). [Электронный ресурс]. - 2020. - 48с. (дата обращения: 08.12.2020). http://www.chelsma.ru/files/misc/kr_miomamatki.pdf

3. Клинические протоколы (гинекология). Изд. 2-е, дополн. / под ред. А.А. Шмидта; коллектив авторов Шмидт А.А. [и др.]. - СПб.: СпецЛит., 2018. - 158 с

4. Vlahos, N.F. Myomas and adenomyosis: impact on reproductive outcome /N.F.Vlahos, T.D Theodoridis., G.A. // Partsinevelos BioMed research international. - 2017. - Т. 2017. DOI: 10.1155/2017/5926470

5. Wise, L.A. Epidemiology of uterine fibroids-from menarche to menopause // L.A. Wise, S.K. Laughlin-Tommaso /Clinical obstetrics and gynecology. - 2016. - Т. 59, №. 1. - С. 2. DOI: 10.1097/GRF.0000000000000164

6. Extracellular matrix in uterine leiomyoma pathogenesis: a potential target for future therapeutics/ M. S. Islam [et al.] //Human reproduc- tion update. - 2018. - Т. 24, №. 1. - С. 59-85. DOI: 10.1093/humupd/dmx032

7. Uterine fibroids/ E. A. Stewart [et al.] //Nature reviews Disease primers. - 2016. - Т. 2, №. 1. - С. 1-18. DOI: 10.1016/S01406736(00)03622-9

8. Paracrine pathways in uterine leiomyoma stem cells involve insulinlike growth factor 2 and insulin receptor A // M. B. Moravek [et al.] / The Journal of Clinical Endocrinology & Metabolism. - 2017. - Т. 102, №. 5. - С. 1588-1595. DOI: 10.1210/jc.2016-3497

9. Uterine fibroid management: today and tomorrow / M.M. Dolmans, J.Donnez, L. Fellah //Journal of Obstetrics and Gynaecology Research. - 2019. - Т. 45, №. 7. - С. 1222-1229. DOI: 10.1111/jog.14002

10. Сидорова, И.С. Клинико-морфологические особенности простой и пролиферирующей миомы матки / И.С. Сидорова, М.Б. Агеев //Российский вестник акушера-гинеколога. - 2013. - Т. 13, №. 6. - С. 34-38

11. Нурмухаметова, Э.Т. Архитектоника миоматозных узлов у женщин, поступивших на лечение методом эмболизации маточных артерий / Э.Т. Нурмухаметова, М.Е. Шляпников, О.Б. Неганова //Вестник медицинского института «Реавиз»: реабилитация, врач и здоровье. - 2019. - №2 (38).- С.48-54

12. Oestrogen-induced angiogenesis and implantation contribute to the development of parasitic myomas after laparoscopic morcellation/ B. S. Huang [et al.] //Reproductive Biology and Endocrinology. - 2016. - Т. 14, №. 1. - С. 1-12. DOI: 10.1186/s12958-016-0200-y

13. Research on genesis of adipocytic metaplasia in uterine fibroids / H. Sośnik [et al.] //Polish Journal of Pathology. - 2015. - Т. 66, №. 4. - С. 403-409. DOI: 10.5114/pjp.2015.57254

14. α-smooth muscle actin is not a marker of fibrogenic cell activity in skeletal muscle fibrosis / W. Zhao [et al.] //PloS one. - 2018. - Т. 13, №. 1. - С. e0191031. DOI: 10.1371/journal.pone.0191031


Review

For citations:


Atayants K.M., Kurmanbaev T.E., Timoshkova Yu.L., Shmidt A.A., Kubasov M.V., Kuzheniyazov A.A. CLINICAL AND MORPHOLOGICAL FEATURES OF UTERINE FIBROID IN PATIENTS OF REPRODUCTIVE AGE. Bashkortostan Medical Journal. 2021;16(1):16-20. (In Russ.)

Views: 72


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1999-6209 (Print)